Search Within

Joseph G Jurcic

Formats
  1. Meeting Abstract (69)
  2. Journal Article (60)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (134)
  2. Hematologic Malignancies, Division of (134)
  3. Center for Hematologic Malignancies (112)
  4. Adult Leukemia (109)
  5. GSK Faculty (99)
  6. Hematologic Malignancies Research (95)

More Groups

People
  1. David Scheinberg (84)
  2. Peter Maslak (44)
  3. Steven Larson (33)
  4. Ronald Finn (26)
  5. Mark Heaney (23)
  6. Michael Mcdevitt (23)

More People

Years
  1. 2018 (1)
  2. 2016 (1)
  3. 2014 (2)
  4. 2013 (4)
  5. 2012 (9)
  6. 2011 (13)

More Years

Publications
  1. Blood (47)
  2. Journal of Clinical Oncology (13)
  3. Journal of Nuclear Medicine (8)
  4. Cancer Biotherapy and Radiopharmaceuticals (6)
  5. Cancer Chemotherapy and Biological Response Modifiers (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (48)
  2. American Society of Clinical Oncology (13)
  3. Elsevier Inc. (12)
  4. Society of Nuclear Medicine (8)
  5. Mary Ann Liebert, Inc (6)
  6. Springer (6)

More Publishers

Results (134)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia
    Journal Article

    Bach, P. B.; Malak, S. F.; Jurcic, J.; Gelfand, S. E.; Eagan, J.; Little, C.; Sepkowitz, K. A.
    Infection Control and Hospital Epidemiology (2002)

    Fulltext@MSK | Save
  • Antibody-based therapy of myeloid leukemia
    Meeting Abstract

    Jurcic, J. G.
    Annals of Hematology (2001)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide: A new active regimen for patients with fludarabine refractory CLL
    Meeting Abstract

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
    Blood (2001)

    Fulltext@MSK | Save
  • Refractory aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin
    Meeting Abstract

    Aliff, T. B.; Maslak, P. G.; Jurcic, J. G.; Heaney, M. L.; Cathcart, K. N.; Weiss, M. A.
    Blood (2001)

    Fulltext@MSK | Save
  • Antibody therapy for residual disease in acute myelogenous leukemia
    Journal Article

    Jurcic, J. G.
    Critical Reviews in Oncology/Hematology (2001)

    Fulltext@MSK | Save
  • Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia
    Journal Article

    Frankel, A. E.; Schuster, M. W.; Jurcic, J. G.
    BioDrugs (2001)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with t(5;18)(q35;q21)
    Journal Article

    Wang, E. S.; Maslak, P.; Cathcart, K.; Jurcic, J. G.
    Cancer Genetics and Cytogenetics (2001)

    Fulltext@MSK | Save
  • Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemia
    Journal Article

    Kolbert, K. S.; Hamacher, K. A.; Jurcic, J. G.; Scheinberg, D. A.; Larson, S. M.; Sgouros, G.
    Journal of Nuclear Medicine (2001)

    Fulltext@MSK | Save
  • Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: Long-term follow-up in acute promyelocytic leukemia
    Journal Article

    Jurcic, J. G.; Nimer, S. D.; Scheinberg, D. A.; Deblasio, T.; Warrell, R. P. Jr; Miller, W. H. Jr
    Blood (2001)

    Fulltext@MSK | Save
  • Phase I trial of yttrium-90-HuM195 (anti-CD33) in myeloid leukemia: Potential for myeloablation
    Meeting Abstract

    Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Hamacher, K. A.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2000)

    Fulltext@MSK | Save